Service d'angiologie

Equipe principale
Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


334 publications

Sous presse | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | ...
 
Oxygen as a key regulator of cardiomyocyte proliferation: New results about cell culture conditions!
Bon-Mathier A.C., Rignault-Clerc S., Bielmann C., Rosenblatt-Velin N. Biochimica et biophysica acta. Molecular cell research. Peer-reviewed.
[DOI] [Pmid] [serval:BIB_9663E3496DD9]
 
Prediction of early mortality in patients with cancer-associated thrombosis in the RIETE database.
Fuentes H.E., Tafur A.J., Caprini J.A., Alatri A., Trujillo-Santos J., Farge-Bancel D., Rosa V., Font L., Vilaseca A., Monreal M. et al. International angiology. Peer-reviewed.
[DOI] [Pmid] [serval:BIB_9723814C34FE]
 
Frequency and prognostic impact of acute kidney injury in patients with acute pulmonary embolism. Data from the RIETE registry.
Murgier M., Bertoletti L., Darmon M., Zeni F., Valle R., Del Toro J., Llamas P., Mazzolai L., Villalobos A., Monreal M. et al., 2019/09/15. International journal of cardiology, 291 pp. 121-126. Peer-reviewed.
 
Urgent need to clarify the definition of chronic critical limb ischemia - a position paper from the European Society for Vascular Medicine.
Constans J., Bura-Rivière A., Visona A., Brodmann M., Abraham P., Olinic D.M., Madaric J., Steiner S., Quéré I., Mazzolai L. et al., 2019/05. VASA. Zeitschrift fur Gefasskrankheiten, 48 (3) pp. 223-227. Peer-reviewed.
Connexin37-Dependent Mechanisms Selectively Contribute to Modulate Angiotensin II -Mediated Hypertension.
Le Gal L., Pellegrin M., Santoro T., Mazzolai L., Kurtz A., Meda P., Wagner C., Haefliger J.A., 2019/04/16. Journal of the American Heart Association, 8 (8) pp. e010823. Peer-reviewed.
 
Management of Patients with Asymptomatic and Symptomatic Carotid Artery Disease: Update on Anti-Thrombotic Therapy.
Pastori D., Eikelboom J.W., Anand S.S., Patel M.R., Tanguay J.F., Ricco J.B., Debus E.S., Mazzolai L., Bauersachs R., Verhamme P. et al., 2019/04. Thrombosis and haemostasis, 119 (4) pp. 576-585. Peer-reviewed.
 
Supramaximal Intensity Hypoxic Exercise and Vascular Function Assessment in Mice.
Lavier J., Beaumann M., Ménetrey S., Mazzolai L., Peyter A.C., Pellegrin M., Millet G.P., 2019/03/15. Journal of visualized experiments 145. Peer-reviewed.
[DOI] [WoS] [Pmid] [serval:BIB_ED664A1697B9]
 
The year 2018 in cardiology: aorta and peripheral circulation.
Aboyans V., Vrsalovic M., Madaric J., Mazzolai L., De Carlo M., ESC Working Group on Aorta and Peripheral Vascular Diseases, 2019/03/14. European heart journal, 40 (11) pp. 872-879. Peer-reviewed.
 
ESVM integrated care pathways - a call for action.
Visonà A., Pesavento R., Mazzolai L., Cimminiello C., Pécsvárady Z., Olinic D., Johansson E., 2019/03. VASA. Zeitschrift fur Gefasskrankheiten, 48 (2) pp. 113-114. Peer-reviewed.
[DOI] [WoS] [Pmid] [serval:BIB_1815DD9C6BE2]
 
Accès vasculaire du patient hémodialysé - Que doit savoir le spécialiste en médecine interne générale ? [The vascular access of hemodialysis patients - What should the primary care physician know about ?]
Pivin E., Cunha Moreira Da Silva F.A., Calanca L., Deglise S., Pruijm M., 2019/02/20. Revue medicale suisse, 15 (639) pp. 439-443. Peer-reviewed.
 
The bleeding risk in antithrombotic therapies: a narrative review.
Alatri A., Mazzolai L., 2019/02/11. Current vascular pharmacology. Peer-reviewed.
 
A high Gas6 level in plasma predicts venous thromboembolism recurrence, major bleeding and mortality in the elderly: a prospective multicenter cohort study.
Schnegg-Kaufmann A., Calzavarini S., Limacher A., Mean M., Righini M., Staub D., Beer J.H., Frauchiger B., Osterwalder J., Kucher N. et al., 2019/02. Journal of thrombosis and haemostasis, 17 (2) pp. 306-318. Peer-reviewed.
 
Anticoagulation à faible dose : is less more ? []
Fontana P., Mazzolai L., Righini M., 2018/12/05. Revue medicale suisse, 14 (630) p. 2191. Peer-reviewed.
 
Traitement médical optimal de l’artériopathie oblitérante des membres inférieurs en 2018 [Best medical treatment of lower extremity arterial disease in 2018]
Buso G., Calanca L., Ney B., Fresa M., Mazzolai L., 2018/12/05. Revue medicale suisse, 14 (630) pp. 2202-2206. Peer-reviewed.
Walking performances and muscle oxygen desaturation are increased after supervised exercise training in Takayasu arteritis: a case report and a review of the literature.
Lanzi S., Calanca L., Borgeat Kaeser A., Mazzolai L., 2018/12. European heart journal. Case reports, 2 (4) pp. yty123. Peer-reviewed.
 
Characteristics, treatment patterns and outcomes of patients presenting with venous thromboembolic events after knee arthroscopy in the RIETE Registry.
Weinberg I., Giri J., Kolluri R., Arcelus J.I., Falgá C., Soler S., Braester A., Bascuñana J., Gutiérrez-Guisado J., Monreal M. et al., 2018/11. Journal of thrombosis and thrombolysis, 46 (4) pp. 551-558. Peer-reviewed.
 
Activation of Bone Marrow-Derived Cells Angiotensin (Ang) II Type 1 Receptor by Ang II Promotes Atherosclerotic Plaque Vulnerability.
Pellegrin M., Bouzourène K., Aubert J.F., Nahimana A., Duchosal M.A., Mazzolai L., 2018/09/04. International journal of molecular sciences, 19 (9) pp. E2621. Peer-reviewed.
 
Commentaries on Viewpoint: V̇o<sub>2peak</sub> is an acceptable estimate of cardiorespiratory fitness but not V̇o<sub>2max</sub>.
Zuo L., Zhou T., Malatesta D., Lanzi S., Millet G.P., Pogliaghi S., Paterson D.H., Murias J.M., van der Zwaard S., Jaspers R.T. et al., 2018/09/01. Journal of applied physiology, 125 (3) pp. 966-967. Peer-reviewed.
[DOI] [WoS] [Pmid] [serval:BIB_A2A41F84847A]
 
Commentaries on Viewpoint: Use aerobic energy expenditure instead of oxygen uptake to quantify exercise intensity and predict endurance performance.
Barnes K.R., Kilding A.E., Blagrove R.C., Howatson G., Hayes P.R., Boone J., Bourgois J., Fletcher J.R., MacIntosh B.R., González-Mohíno F. et al., 2018/08/01. Journal of applied physiology, 125 (2) pp. 676-682. Peer-reviewed.
 
Derivation and Validation of a Prediction Model for Risk Stratification of Post-Thrombotic Syndrome in Elderly Patients with a First Deep Vein Thrombosis.
Méan M., Limacher A., Alatri A., Aujesky D., Mazzolai L., 2018/08. Thrombosis and haemostasis, 118 (8) pp. 1419-1427. Peer-reviewed.
 
Impact of Thyroid Hormone Therapy on Atherosclerosis in the Elderly With Subclinical Hypothyroidism: A Randomized Trial.
Blum M.R., Gencer B., Adam L., Feller M., Collet T.H., da Costa B.R., Moutzouri E., Dopheide J., Depairon M., Sykiotis G.P. et al., 2018/08/01. The Journal of clinical endocrinology and metabolism, 103 (8) pp. 2988-2997. Peer-reviewed.
 
Impact of Thrombus Sidedness on Presentation and Outcomes of Patients with Proximal Lower Extremity Deep Vein Thrombosis.
Bikdeli B., Sharif-Kashani B., Bikdeli B., Valle R., Falga C., Riera-Mestre A., Mazzolai L., Verhamme P., Wells P.S., Torrero JFSM et al., 2018/06. Seminars in thrombosis and hemostasis, 44 (4) pp. 341-347. Peer-reviewed.
 
Predictors and Outcomes of Recurrent Venous Thromboembolism in Elderly Patients.
Lauber S., Limacher A., Tritschler T., Stalder O., Méan M., Righini M., Aschwanden M., Beer J.H., Frauchiger B., Osterwalder J. et al., 2018/06. The American journal of medicine, 131 (6) pp. 703.e7-703.e16. Peer-reviewed.
Experimental Drainage Device to Reduce Lymphoedema in a Rat Model.
Triacca V., Pisano M., Lessert C., Petit B., Bouzourene K., Nahimana A., Vozenin M.C., Stergiopulos N., Swartz M.A., Mazzolai L., 2018/05/25. European journal of vascular and endovascular surgery. Peer-reviewed.
Chemical shift encoding (CSE) for sensitive fluorine-19 MRI of perfluorocarbons with complex spectra.
van Heeswijk R.B., Colotti R., Darçot E., Delacoste J., Pellegrin M., Piccini D., Hernando D., 2018/05. Magnetic resonance in medicine, 79 (5) pp. 2724-2730. Peer-reviewed.
 
Pathophysiology of telangiectasias of the lower legs and its therapeutic implication: A systematic review.
Kern P., 2018/05. Phlebology, 33 (4) pp. 225-233. Peer-reviewed.
 
Suitability for catheter-directed thrombolysis in patients with acute lower extremity deep vein thrombosis according to various international consensus guidelines.
Stefanescu A., Alatri A., Périard D., Kucher N., Mazzolai L., Engelberger R.P., 2018/05. Thrombosis research, 165 pp. 112-115. Peer-reviewed.
 
Anemia and bleeding in patients receiving anticoagulant therapy for venous thromboembolism.
Kuperman A., López-Reyes R., Bosco L.J., Lorenzo A., José B., Farge Bancel D., Alfonso M., Lumbierres M., Stemer G., Monreal Bosch M. et al., 2018/04. Journal of thrombosis and thrombolysis, 45 (3) pp. 360-368. Peer-reviewed.
 
Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism.
Chai-Adisaksopha C., Iorio A., Crowther M.A., de Miguel J., Salgado E., Zdraveska M., Fernández-Capitán C., Nieto J.A., Barillari G., Bertoletti L. et al., 2018/04. The American journal of medicine, 131 (4) pp. 430-437. Peer-reviewed.
 
Editor's Choice - 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS).
Aboyans V., Ricco J.B., Bartelink MEL, Björck M., Brodmann M., Cohnert T., Collet J.P., Czerny M., De Carlo M., Debus S. et al., 2018/03. European journal of vascular and endovascular surgery, 55 (3) pp. 305-368. Peer-reviewed.
 
Questions and answers on diagnosis and management of patients with Peripheral Arterial Diseases: a companion document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Endorsed by: the European Stroke Organisation (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS).
Aboyans V., Björck M., Brodmann M., Collet J.P., Czerny M., De Carlo M., Naylor A.R., Roffi M., Tendera M., Vlachopoulos C. et al., 2018/03/01. European heart journal, 39 (9) pp. e35-e41. Peer-reviewed.
 
The year 2017 in cardiology: aorta and peripheral circulation.
Aboyans V., Braekkan S., Mazzolai L., Sillesen H., Venermo M., De Carlo M., ESC Working Group on Aorta and Peripheral Vascular Diseases, 2018/03/01. European heart journal, 39 (9) pp. 730-738. Peer-reviewed.
 
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS).
Aboyans V., Ricco J.B., Bartelink MEL, Bjorck M., Brodmann M., Cohnert T., Collet J.P., Czerny M., De Carlo M., Debusa S. et al., 2018/02. Revista espanola de cardiologia, 71 (2) p. 111. Peer-reviewed.
[DOI] [WoS] [Pmid] [serval:BIB_C9B9B605B014]
Angiotensinergic Innervation of the Human Right Atrium: Implications for Cardiac Reflexes.
Bohlender J.M., Nussberger J., Tevaearai H., Imboden H., 2018/01/12. American journal of hypertension, 31 (2) pp. 188-196. Peer-reviewed.
 
Il est temps d’agir! []
Mazzolai L., 2018. Praxis, 107 (20) p. 1069. Peer-reviewed.
 
Le lipœdème, cet inconnu [Lipedema, the Unknown]
Depairon M., Tomson D., Lessert C., Mazzolai L., 2018. Praxis, 107 (20) pp. 1071-1076. Peer-reviewed.
 
Supramaximal intensity hypoxic exercise in mice: feasibility and vascular function assessment
Lavier J., Beaumann M., Menetrey S., Mazzolai L., Peyter A.L., Pellegrin M., Millet G P, 2018. JoVE. Peer-reviewed.
[serval:BIB_97F19EEB2DD0]
 
Le défi des maladies vasculaires rares : l’union fait la force ! []
Mazzolai L., Fontana P., Righini M., 2017/12/06. Revue medicale suisse, 13 (586) p. 2107. Peer-reviewed.
 
Lymphœdème primaire [Primary lymphedema]
Depairon M., Lessert C., Tomson D., Mazzolai L., 2017/12/06. Revue medicale suisse, 13 (586) pp. 2124-2128. Peer-reviewed.
 
Maladies vasculaires rares, mise en place d’un centre multidisciplinaire spécialisé au CHUV [Rare vascular diseases, building dedicated multidisciplinary specialized center]
Krieger C., Baud D., Bouchardy J., Christen-Zaech S., De Buys A., Deglise S., El Ezzi O., Fresa M., Hofer M., Hohl D. et al., 2017/12/06. Revue medicale suisse, 13 (586) pp. 2109-2115. Peer-reviewed.
 
Thromboangéite oblitérante :notions pour la pratique [Thromboangiitis obliterans: notions for practice]
Calanca L., Alatri A., Krieger C., Corpataux J.M., Mazzolai L., 2017/12/06. Revue medicale suisse, 13 (586) pp. 2129-2133. Peer-reviewed.
 
Thromboses veineuses profondes de localisation inhabituelle [Deep vein thrombosis in uncommon localisations]
Erdmann A., Ney B., Qanadli S.D., Calanca L., Mazzolai L., 2017/12/06. Revue medicale suisse, 13 (586) pp. 2134-2137. Peer-reviewed.
 
Traitement des malformations veineuses chez l’adulte : rôle de la sclérothérapie échoguidée [The treatment of venous malformations in adult patients: the role of US-guided sclerotherapy]
Fresa M., Erdmann A., El Ezzi O., De Buys A., Depairon M., Dabiri A., Ney B., Mazzolai L., 2017/12/06. Revue medicale suisse, 13 (586) pp. 2116-2120. Peer-reviewed.
 
Long-term outcomes of elderly patients with CYP2C9 and VKORC1 variants treated with vitamin K antagonists.
Nagler M., Angelillo-Scherrer A., Méan M., Limacher A., Abbal C., Righini M., Beer J.H., Osterwalder J., Frauchiger B., Aschwanden M. et al., 2017/11. Journal of thrombosis and haemostasis, 15 (11) pp. 2165-2175. Peer-reviewed.
 
The Modified Ottawa Score and Clinical Events in Hospitalized Patients with Cancer-Associated Thrombosis from the Swiss VTE Registry.
Alatri A., Mazzolai L., Kucher N., Aujesky D., Beer J.H., Baldi T., Banyai M., Hayoz D., Kaeslin T., Korte W. et al., 2017/11. Seminars in thrombosis and hemostasis, 43 (8) pp. 871-876. Peer-reviewed.
Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism.
Moustafa F., Giorgi Pierfranceschi M., Di Micco P., Bucherini E., Lorenzo A., Villalobos A., Nieto J.A., Valero B., Sampériz Á.L., Monreal M. et al., 2017/10. Research and practice in thrombosis and haemostasis, 1 (2) pp. 172-179. Peer-reviewed.
 
Hypertension et dysplasie fibromusculaire :au-delà des artères rénales [Fibromuscular dysplasia and hypertension : beyond renal arteries]
Wuerzner G., Krieger C., Bouchardy J., Toubiana L., Delmotte P., Van der Niepen P., Déglise S., Qanadli S., Burnier M., Mazzolai L. et al., 2017/09/13. Revue medicale suisse, 13 (574) pp. 1580-1583. Peer-reviewed.
 
Systemic and tissue-specific effects of aliskiren on the RAAS and carbohydrate/lipid metabolism in obese patients with hypertension.
Engeli S., May M., Nussberger J., Danser AHJ, Dole W.P., Prescott M.F., Dahlke M., Stitah S., Pal P., Boschmann M. et al., 2017/08. Journal of the American Society of Hypertension, 11 (8) pp. 488-497. Peer-reviewed.
 
Low discriminating power of the modified Ottawa VTE risk score in a cohort of patients with cancer from the RIETE registry.
Alatri A., Mazzolai L., Font C., Tafur A., Valle R., Marchena P.J., Ballaz A., Tiraferri E., Font L., Monreal M. et al., 2017/07/26. Thrombosis and haemostasis, 117 (8) pp. 1630-1636. Peer-reviewed.
 
Are ACE inhibitors acceptable ingredients in polypills?
Messerli F.H., Bangalore S., Rimoldi S.F., Gąsowski J., Nussberger J., 2017/07/01. Lancet, 390 (10089) p. 26. Peer-reviewed.
 
Tip malposition of peripherally inserted central catheters: a prospective randomized controlled trial to compare bedside insertion to fluoroscopically guided placement.
Glauser F., Breault S., Rigamonti F., Sotiriadis C., Jouannic A.M., Qanadli S.D., 2017/07. European radiology, 27 (7) pp. 2843-2849. Peer-reviewed.
 
Prévalence d’une sténose carotidienne chez le nonagénaire : résultats d’une enquête hospitalière [Prevalence of carotid artery stenosis in nonagenarians: Survey in a primary care hospital]
Bohlender J., Nussberger J., Ménard J., Bohlender B., 2017/06. Annales de cardiologie et d'angeiologie, 66 (3) pp. 130-134. Peer-reviewed.
 
Resetting of renal tissular renin-angiotensin and bradykinin-kallikrein systems after unilateral kidney denervation in rats.
Bohlender J.M., Nussberger J., Birkhäuser F., Grouzmann E., Thalmann G.N., Imboden H., 2017/05. Histochemistry and cell biology, 147 (5) pp. 585-593. Peer-reviewed.
 
Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism.
Barrios D., Chavant J., Jiménez D., Bertoletti L., Rosa-Salazar V., Muriel A., Viallon A., Fernández-Capitán C., Yusen R.D., Monreal M. et al., 2017/05. The American journal of medicine, 130 (5) pp. 588-595. Peer-reviewed.
 
The year in cardiology 2016: peripheral circulation.
De Carlo M., Mazzolai L., Bossone E., Brodmann M., Micari A., Muiesan M.L., Ricco J.B., Stabile E., Agnelli G., Aboyans V. et al., 2017/04/07. European heart journal, 38 (14) pp. 1028-1033. Peer-reviewed.
 
Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation.
Tzoran I., Papadakis M., Brenner B., Fidalgo Á., Rivas A., Wells P.S., Gavín O., Adarraga M.D., Moustafa F., Monreal M. et al., 2017/04. The American journal of medicine, 130 (4) pp. 482.e1-482.e9. Peer-reviewed.
 
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism.
Weitz J.I., Lensing AWA, Prins M.H., Bauersachs R., Beyer-Westendorf J., Bounameaux H., Brighton T.A., Cohen A.T., Davidson B.L., Decousus H. et al., 2017/03/30. The New England journal of medicine, 376 (13) pp. 1211-1222. Peer-reviewed.
 
Prise en charge interventionnelle de l’insuffisance veineuse superficielle des membres inférieurs [Interventional treatment of venous insufficiency]
Ney B., Engelberger R.P., Dabiri A., Lüthi J.F., Erdmann A., Krieger C., Déglise S., Merminod T., Kern P., Mazzolai L., 2017/03/15. Revue medicale suisse, 13 (554) pp. 618-622. Peer-reviewed.
 
Development of a Risk Prediction Score for Occult Cancer in Patients With VTE.
Jara-Palomares L., Otero R., Jimenez D., Carrier M., Tzoran I., Brenner B., Margeli M., Praena-Fernandez J.M., Grandone E., Monreal M. et al., 2017/03. Chest, 151 (3) pp. 564-571. Peer-reviewed.
 
Outcome after discontinuing anticoagulant therapy in women with venous thromboembolism during hormonal use.
Blanco-Molina Á., Trujillo-Santos J., Pesavento R., Rosa V., Falgá C., Tolosa C., Mazzolai L., Sampériz Á., Duce R., Monreal M. et al., 2017/03. Thrombosis research, 151 Suppl 1 pp. S6-S10. Peer-reviewed.
 
The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site.
Mahé I., Chidiac J., Bertoletti L., Font C., Trujillo-Santos J., Peris M., Pérez Ductor C., Nieto S., Grandone E., Monreal M. et al., 2017/03. The American journal of medicine, 130 (3) pp. 337-347. Peer-reviewed.
 
Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European society of cardiology working groups of aorta and peripheral circulation and pulmonary circulation and right ventricular function.
Mazzolai L., Aboyans V., Ageno W., Agnelli G., Alatri A., Bauersachs R., Brekelmans M.P., Büller H.R., Elias A., Farge D. et al., 2017/02/17. European heart journal. Peer-reviewed.
 
Predictors and Causes of Long-Term Mortality in Elderly Patients with Acute Venous Thromboembolism: A Prospective Cohort Study.
Faller N., Limacher A., Méan M., Righini M., Aschwanden M., Beer J.H., Frauchiger B., Osterwalder J., Kucher N., Lämmle B. et al., 2017/02. The American journal of medicine, 130 (2) pp. 198-206. Peer-reviewed.
 
Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry.
Newton D.H., Monreal Bosch M., Amendola M., Wolfe L., Perez Ductor C., Lecumberri R., Levy M.M., RIETE Investigators, 2017/01. Journal of vascular surgery. Venous and lymphatic disorders, 5 (1) pp. 18-24.e1. Peer-reviewed.
 
Bradykinin in idiopathic non-histaminergic angioedema.
Cugno M., Tedeschi A., Nussberger J., 2017/01. Clinical and experimental allergy, 47 (1) pp. 139-140. Peer-reviewed.
 
Mastering Mitral Leaflets Coaptation After Valve Repair with Adjustable Mitral Annuloplasty Ring: Proof of Concept in Mock Loop Study.
Tozzi P., Hayoz D., Antona C., Fiore G.B., Siniscalchi G., Ferrari E., Baeriswyl G., Vismara R., 2017. ASAIO journal (American Society for Artificial Internal Organs : 1992), 63 (2) pp. 168-173. Peer-reviewed.
 
Intérêt de l’échographie de contraste aux microbulles en médecine vasculaire [Relevance of contrast ultrasound with microbubbles in vascular medecine]
Erdmann A., Ney B., Alatri A., Calanca L., Mazzolai L., 2016/12/07. Revue medicale suisse, 12 (542) pp. 2131-2134. Peer-reviewed.
 
La maladie thrombo-embolique veineuse : une pathologie souvent oubliée
Righini M., Fontana P., Mazzolai L., 2016/12/07. Revue medicale suisse, 12 (542) pp. 2099-2100. Peer-reviewed.
 
Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double-blind, placebo-controlled trial.
Righini M., Galanaud J.P., Guenneguez H., Brisot D., Diard A., Faisse P., Barrellier M.T., Hamel-Desnos C., Jurus C., Pichot O. et al., 2016/12. The Lancet. Haematology, 3 (12) pp. e556-e562. Peer-reviewed.
 
Claire Douillard, Pascal Houillier, Juerg Nussberger and Xavier Girerd in response to the correspondence by Damien Denimal entitled: "Comments on French SFE/SFHTA/AFCE Consensus on Primary aldosteronism, Part 2: Diagnosis First steps". Ann Endocrinol 2016.
Douillard C., Houillier P., Nussberger J., Girerd X., 2016/12. Annales d'endocrinologie, 77 (6) p. 676. Peer-reviewed.
[DOI] [Pmid] [serval:BIB_9E304BC94922]
 
Claire Douillard, Pascal Houillier, Juerg Nussberger and Xavier Girerd in response to the correspondence by Damien Denimal entitled: "Comments on French SFE/SFHTA/AFCE Consensus on Primary aldosteronism, Part 2: Diagnosis First steps". Ann Endocrinol 2016.
Douillard C., Houillier P., Nussberger J., Girerd X., 2016/12. Annales d'endocrinologie, 77 (6) p. 676. Peer-reviewed.
 
Pneumopathie toxique à la nitrofurantoïne
Tornay Joséphine , Lazor Romain , Uldry Christophe , Coronado Marcos , 2016/12/01. Schweizerisches Medizin-Forum pp. 973–976.
 
Venous thromboembolism in centenarians: Findings from the RIETE registry.
Lacruz B., Tiberio G., Núñez M.J., López-Jiménez L., Riera-Mestre A., Tiraferri E., Verhamme P., Mazzolai L., González J., Monreal M. et al., 2016/12. European journal of internal medicine, 36 pp. 62-66. Peer-reviewed.
 
Outcome during and after anticoagulant therapy in cancer patients with incidentally found pulmonary embolism.
Peris M., Jiménez D., Maestre A., Font C., Tafur A.J., Mazzolai L., Xifre B., Skride A., Dentali F., Monreal M. et al., 2016/11. The European respiratory journal, 48 (5) pp. 1360-1368. Peer-reviewed.
Unusual circadian hypertension associated with polydipsia.
Bohlender J.M., Nussberger J., 2016/11. Journal of geriatric cardiology : JGC, 13 (11) pp. 932-934. Peer-reviewed.
 
Antihypertensive treatment and risk of brain ischemia due to carotid stenosis in a survey of hospitalised patients aged 90 years and older
Bohlender Jürgen, Nussberger Jürg, Bohlender Beate, 2016/09., 26th Meeting of the International Society of Hypertension pp. e224 dans ISH 2016 Abstract Book, Journal of Hypertension.
 
Rivaroxaban for the treatment of venous thromboembolism. The SWIss Venous ThromboEmbolism Registry (SWIVTER).
Kucher N., Aujesky D., Beer J.H., Mazzolai L., Baldi T., Banyai M., Hayoz D., Kaeslin T., Korte W., Escher R. et al., 2016/08/30. Thrombosis and haemostasis, 116 (3) pp. 472-479.
 
SFE/SFHTA/AFCE Consensus on Primary Aldosteronism, part 2: First diagnostic steps.
Douillard C., Houillier P., Nussberger J., Girerd X., 2016/07. Annales d'endocrinologie, 77 (3) pp. 192-201. Peer-reviewed.
[DOI] [Pmid] [serval:BIB_38E4FBD8B60F]
 
SFE/SFHTA/AFCE primary aldosteronism consensus: Introduction and handbook.
Amar L., Baguet J.P., Bardet S., Chaffanjon P., Chamontin B., Douillard C., Durieux P., Girerd X., Gosse P., Hernigou A. et al., 2016/07. Annales d'endocrinologie, 77 (3) pp. 179-186. Peer-reviewed.
[DOI] [Pmid] [serval:BIB_5E77715BCDCD]
Associations Between Cardiovascular Risk Factors, Inflammation, and Progression of Carotid Atherosclerosis Among Smokers.
Zingg S., Collet T.H., Locatelli I., Nanchen D., Depairon M., Bovet P., Cornuz J., Rodondi N., 2016/06. Nicotine & tobacco research, 18 (6) pp. 1533-1538. Peer-reviewed.
 
Maladie de Rendu-Osler. Manifestations cliniques et prise en charge multidisciplinaire [Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): clinical manifestations and multidisciplinary management]
Frigerio C., Aebischer N., Baud D., Bonafe L., Fellmanne F., Ikonomidis C., Mazzolai L., Michel P., Nichita C., Qanadli S.D. et al., 2016/05/04. Revue medicale suisse, 12 (517) pp. 896-901. Peer-reviewed.
 
Nitric Oxide Deficit Drives Intimal Hyperplasia in Mouse Models of Hypertension.
Allagnat F., Haefliger J.A., Lambelet M., Longchamp A., Bérard X., Mazzolai L., Corpataux J.M., Déglise S., 2016/05. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 51 (5) pp. 733-742. Peer-reviewed.
 
Running Exercise and Angiotensin II Type I Receptor Blocker Telmisartan Are Equally Effective in Preventing Angiotensin II-Mediated Vulnerable Atherosclerotic Lesions.
Pellegrin M., Szostak J., Bouzourène K., Aubert J.F., Berthelot A., Nussberger J., Laurant P., Mazzolai L., 2016/04/30. Journal of cardiovascular pharmacology and therapeutics, 22 (2) pp. 159-168. Peer-reviewed.
 
Clinical Outcomes of Venous Thromboembolism in Patients with and without Cancer: The SWIss Venous ThromboEmbolism Registry (SWIVTER).
Spirk D., Aujesky D., Stuck A.K., Beer J.H., Mazzolai L., Baldi T., Banyai M., Hayoz D., Kaeslin T., Korte W. et al., 2016/04. Seminars in thrombosis and hemostasis, 42 (6) pp. 642-649. Peer-reviewed.
[DOI] [Pmid] [serval:BIB_49F7356A5CF9]
 
Infection as cause of immobility and occurrence of venous thromboembolism: analysis of 1635 medical cases from the RIETE registry.
Frasson S., Gussoni G., Di Micco P., Barba R., Bertoletti L., Nuñez M.J., Valero B., Samperiz A.L., Rivas A., Monreal M. et al., 2016/04. Journal of thrombosis and thrombolysis, 41 (3) pp. 404-412.
 
The year in cardiology 2015: peripheral circulation.
Aboyans V., De Carlo M., Kownator S., Mazzolai L., Meneveau N., Ricco J.B., Vlachopoulos C., Brodmann M., ESC Working Group on Peripheral Circulation, 2016/02/21. European heart journal, 37 (8) pp. 676-685. Peer-reviewed.
 
Trends in the Management and Outcomes of Acute Pulmonary Embolism: Analysis From the RIETE Registry.
Jiménez D., de Miguel-Díez J., Guijarro R., Trujillo-Santos J., Otero R., Barba R., Muriel A., Meyer G., Yusen R.D., Monreal M. et al., 2016/01/19. Journal of the American College of Cardiology, 67 (2) pp. 162-170.
 
Accuracy of in-patients ankle-brachial index measurement by medical students
Monti M., Calanca L., Alatri A., Mazzolai L., 2016. European Journal of Vascular Medicine, 45 (1) pp. 43-48.
 
Accuracy of in-patients ankle-brachial index measurement by medical students.
Monti M., Calanca L., Alatri A., Mazzolai L., 2016. Vasa. Zeitschrift Für Gefässkrankheiten, 45 (1) pp. 43-48. Peer-reviewed.
 
Anticoagulation and Renal Insufficiency.
Koulouri A., Calanca L., Mazzolai L., 2016. Therapeutische Umschau. Revue therapeutique, 73 (10) pp. 567-572. Peer-reviewed.
Diabète gestationnel--quelles sont les approches non médicales [Gestational diabetes--what are the non-medical approaches?].
Horsch A., Gross J., Jornayvaz F.R., Lanzi S., Puder J.J., 2016. Revue Médicale Suisse, 12 (521) pp. 1089-1091. Peer-reviewed.
 
Myocardial infarction after ultrasoundguided foam sclerotherapy for varicose veins--a case report and review of the literature of a rare but serious adverse event.
Engelberger R.P., Ney B., Clair M., Dabiri A., Alatri A., Mazzolai L., Kern P., 2016. Vasa. Zeitschrift Für Gefässkrankheiten, 45 (3) pp. 255-258. Peer-reviewed.
 
Prevalence and risk factors for venous thromboembolic complications in the Swiss Inflammatory Bowel Disease Cohort.
Alatri A., Schoepfer A., Fournier N., Engelberger R.P., Safroneeva E., Vavricka S., Biedermann L., Calanca L., Mazzolai L., Swiss IBD Cohort Study Group, 2016. Scandinavian Journal of Gastroenterology, 51 (10) pp. 1200-1205. Peer-reviewed.
9/11 and the Literature of Terror, by Martin Randall
Soltysik Monnet A., 2015/10. Modern Language Review, 110 (4) pp. 1126-1128. Peer-reviewed.
 
A RIETE registry analysis of recurrent thromboembolism and hemorrhage in patients with catheter-related thrombosis.
Baumann Kreuziger L., Cote L., Verhamme P., Greenberg S., Caprini J., Muñoz F.J., Valle R., Monreal Bosch M., RIETE Investigators, 2015/07. Journal of vascular surgery. Venous and lymphatic disorders, 3 (3) pp. 243-50.e1.
 
Subsequent arterial ischemic events in patients receiving anticoagulant therapy for venous thromboembolism.
Madridano O., del Toro J., Lorenzo A., Martín M., Gómez Cerezo J., Hernández L., Prandoni P., Monreal M., RIETE Investigators, 2015/04. Journal of vascular surgery. Venous and lymphatic disorders, 3 (2) pp. 135-41.e1.
 
Anomalies vasculaires: exemple du syndrome de Klippel-Trenaunay [Vascular anomalies].
Krieger Caroline Ade B, Roessingh Ade B, Depairon M., El Ezzi O., Hohlfeld J., Raffoul W., Qanadli S.D., Mazzolai L., 2015/02. Revue Médicale Suisse, 11 (460) pp. 357-361.
 
A Prognostic Score to Identify Low-risk Outpatients with Acute Deep Vein Thrombosis in the Lower Limbs.
Trujillo-Santos J., Lozano F., Lorente M.A., Adarraga D., Hirmerova J., Del Toro J., Mazzolai L., Barillari G., Barrón M., Monreal M. et al., 2015. American Journal of Medicine, 128 (1) pp. 90.e9-90.e15. Peer-reviewed.
 
A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the upper extremity.
Rosa-Salazar V., Trujillo-Santos J., Díaz Peromingo J.A., Apollonio A., Sanz O., Malý R., Muñoz-Rodriguez F.J., Serrano J.C., Soler S., Monreal M. et al., 2015. Journal of Thrombosis and Haemostasis : Jth, 13 (7) pp. 1274-1278. Peer-reviewed.
 
Artériopathies non athéromateuses des membres inférieurs [Non atherosclerotic arterial disease of lower limbs].
Calanca L., Alatri A., Depairon M., Engelberger R.P., Mazzolai L., 2015. Revue Médicale Suisse, 11 (460) pp. 352, 354-352, 356.
 
Biological variation of established and novel biomarkers for atherosclerosis: Results from a prospective, parallel-group cohort study.
Engelberger R.P., Limacher A., Kucher N., Baumann F., Silbernagel G., Benghozi R., Do D.D., Willenberg T., Baumgartner I., 2015. Clinica Chimica Acta, 447 pp. 16-22. Peer-reviewed.
 
CO-10: Are hospitalised patients aged 90 years and over treated well for hypertension? Lessons from a prospective survey.
Bohlender J., Nussberger J., Bohlender B., 2015. Annales de Cardiologie et d'angéiologie, 64 (Suppl 1) pp. S7. Peer-reviewed.
[DOI] [Pmid] [serval:BIB_3FCC9C6F40C1]
 
Duration of anticoagulation after venous thromboembolism in real world clinical practice.
Ageno W., Samperiz A., Caballero R., Dentali F., Di Micco P., Prandoni P., Becattini C., Uresandi F., Verhamme P., Monreal M. et al., 2015. Thrombosis Research, 135 (4) pp. 666-672. Peer-reviewed.
 
Expression and functional role of the prorenin receptor in the human adrenocortical zona glomerulosa and in primary aldosteronism.
Recarti C., Seccia T.M., Caroccia B., Gonzales-Campos A., Ceolotto G., Lenzini L., Petrelli L., Belloni A.S., Rainey W.E., Nussberger J. et al., 2015. Journal of Hypertension, 33 (5) pp. 1014-1022. Peer-reviewed.
Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism.
Farge D., Trujillo-Santos J., Debourdeau P., Bura-Riviere A., Rodriguez-Beltrán E.M., Nieto J.A., Peris M.L., Zeltser D., Mazzolai L., Hij A. et al., 2015. Medicine, 94 (32) pp. e1235. Peer-reviewed.
Fluorine MR Imaging of Inflammation in Atherosclerotic Plaque in Vivo.
van Heeswijk R.B., Pellegrin M., Flögel U., Gonzales C., Aubert J.F., Mazzolai L., Schwitter J., Stuber M., 2015. Radiology, 275 (2) pp. 421-429. Peer-reviewed.
 
Fondaparinux in the initial and long-term treatment of venous thromboembolism.
Pesavento R., Amitrano M., Trujillo-Santos J., Di Micco P., Mangiacapra S., López-Jiménez L., Falgá C., García-Bragado F., Piovella C., Prandoni P. et al., 2015. Thrombosis Research, 135 (2) pp. 311-317. Peer-reviewed.
 
Gender differences in cancer patients with acute venous thromboembolism.
Martín-Martos F., Trujillo-Santos J., Barrón M., Vela J., Javier Marchena P., Braester A., Hij A., Hernández-Blasco L., Verhamme P., Manuel M. et al., 2015. Thrombosis Research, 135 Suppl 1 pp. S12-S15.
 
Identification of Low-Risk Patients with Acute Symptomatic Pulmonary Embolism for Outpatient Therapy.
Maestre A., Trujillo-Santos J., Riera-Mestre A., Jiménez D., Di Micco P., Bascuñana J., Vela J.R., Peris L., Malfante P.C., Monreal M. et al., 2015. Annals of the American Thoracic Society, 12 (8) pp. 1122-1129. Peer-reviewed.
 
Initiation of rivaroxaban in patients with nonvalvular atrial fibrillation at the primary care level: the Swiss Therapy in Atrial Fibrillation for the Regulation of Coagulation (STAR) Study.
Engelberger R.P., Noll G., Schmidt D., Alatri A., Frei B., Kaiser W.E., Kucher N., 2015. European Journal of Internal Medicine, 26 (7) pp. 508-514. Peer-reviewed.
 
Interplay between connexin40 and nitric oxide signaling during hypertension.
Le Gal L., Alonso F., Mazzolai L., Meda P., Haefliger J.A., 2015. Hypertension, 65 (4) pp. 910-915. Peer-reviewed.
 
La maladie thromboembolique veineuse: cette "inconnue" [Venous thromboembolism: the "unknown"].
Mazzolai L., 2015. Revue Médicale Suisse, 11 (460) p. 335.
 
Le cophénotype sympathique efférent des fibres autonomes angiotensinergiques dans le coeur humain. [Autonomic angiotensinergic fibres in the human heart with an efferent sympathetic cophenotype]
Bohlender J., Nussberger J., Tevaearai H., Imboden H., 2015. Annales de Cardiologie et d'Angéiologie, 64 (3) pp. 175-179. Peer-reviewed.
Long-Term Anticoagulant Therapy of Patients with Venous Thromboembolism. What Are the Practices?
Mahé I., Sterpu R., Bertoletti L., López-Jiménez L., Mellado Joan M., Trujillo-Santos J., Ballaz A., Hernández Blasco L.M., Marchena P.J., Monreal M. et al., 2015. Plos One, 10 (6) pp. e0128741. Peer-reviewed.
 
Pathologies vasculaires lymphatiques: apport de la lympho-fluoroscopie [Lymphatic vascular pathologies: contribution of lympho-fluoroscopy].
Tomson D., Lessert C., Luthi I., Mazzolai L., Depairon M., 2015. Revue Médicale Suisse, 11 (460) pp. 362-365.
 
Point-of-Care-Sonografie: Let's keep it simple [Point of care ultrasound].
Gretener S.B., Bieri T., Canova C.R., Engelberger R.P., Küpfer S., Lyrer P., Meuwly J.Y., Staub D., Thalhammer C., 2015. Praxis, 104 (19) pp. 1033-1035.
Prevalence and risk factors for thromboembolic complications in IBD patients
Schoepfer A., Alatri A., Fournier N., Safroneeva E., Calanca L., Mazzolai L., 2015., 10th Congress of ECCO-European Crohns & Colitis Organisation : Inflammatory bowel diseases. 18-21 February 2015, Barcelona, Spain pp. S178-S179 dans Journal of Crohn's & Colitis, Vol. 9 supl.1. Peer-reviewed.
 
Quelle prise en charge pour une suspicion de thrombose veineuse profonde des membres inférieurs [Suspicion of lower limb deep vein thrombosis: update on diagnosis and treatment].
Erdmann A., Alatri A., Engelberger R.P., Depairon M., Calanca L., Mazzolai L., 2015. Revue Médicale Suisse, 11 (460) pp. 337-341.
Sildenafil as a therapeutic option for digital ischemic ulceration: case report.
Krähenbühl S.M., Depairon M., Faure M., Vietti Violi N., Applegate L.A., Raffoul W., 2015. Journal of Hand Surgery, 40 (5) pp. 890-893. Peer-reviewed.
Staphylococcal biofilm formation on the surface of three different calcium phosphate bone grafts: a qualitative and quantitative in vivo analysis.
Furustrand Tafin U., Betrisey B., Bohner M., Ilchmann T., Trampuz A., Clauss M., 2015. Journal of Materials Science. Materials in Medicine, 26 (3) p. 130. Peer-reviewed.
 
The Atherosclerosis Burden Score (ABS): a Convenient Ultrasound-Based Score of Peripheral Atherosclerosis for Coronary Artery Disease Prediction.
Yerly P., Marquès-Vidal P., Owlya R., Eeckhout E., Kappenberger L., Darioli R., Depairon M., 2015. Journal of Cardiovascular Translational Research, 8 (2) pp. 138-147. Peer-reviewed.
 
The impact of disseminated intravascular coagulation on the outcome of cancer patients with venous thromboembolism.
Spiezia L., Campello E., Trujillo-Santos J., Piovella C., Brenner B., Monreal M., Prandoni P., RIETE Investigators, 2015. Blood Coagulation and Fibrinolysis : An International Journal In Haemostasis and Thrombosis, 26 (6) pp. 709-711. Peer-reviewed.
 
The year in cardiology 2014: peripheral circulation.
Aboyans V., Brodmann M., De Carlo M., Clement D., Mazzolai L., van Bortel L., van Sambeek M.R., Vlachopoulos C., On Behalf the ESC Working Group of Peripheral Circulation, 2015. European Heart Journal, 36 (10) pp. 591-597. Peer-reviewed.
 
Traitement percutané de la thrombose veineuse profonde aiguë [Catheter-based treatment for acute deep vein thrombosis].
Engelberger R.P., Alatri A., Qanadli S.D., Calanca L., Mazzolai L., 2015. Revue Médicale Suisse, 11 (460) pp. 348-351. Peer-reviewed.
Ultra-high-resolution 3D imaging of atherosclerosis in mice with synchrotron differential phase contrast: a proof of concept study.
Bonanno G., Coppo S., Modregger P., Pellegrin M., Stuber A., Stampanoni M., Mazzolai L., Stuber M., van Heeswijk R.B., 2015. Scientific Reports, 5 p. 11980. Peer-reviewed.
 
Ultrasound-assisted versus conventional catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis.
Engelberger R.P., Spirk D., Willenberg T., Alatri A., Do D.D., Baumgartner I., Kucher N., 2015. Circulation. Cardiovascular Interventions, 8 (1) pp. e002027. Peer-reviewed.
 
Venous thromboembolism in patients immobilised at home.
López-Reyes R., Nauffal D., Ballester M., Martín-Antorán J.M., de Sousa M.S., Riera-Mestre A., Ruiz-Ruiz J., Fernández-Capitán C., Uresandi F., Monreal M. et al., 2015. European Respiratory Journal, 45 (6) pp. 1728-1731. Peer-reviewed.
Voluntary Exercise Stabilizes Established Angiotensin II-Dependent Atherosclerosis in Mice through Systemic Anti-Inflammatory Effects.
Pellegrin M., Aubert J.F., Bouzourène K., Amstutz C., Mazzolai L., 2015. Plos One, 10 (11) pp. e0143536. Peer-reviewed.
 
Traitement de l'ischémie critique chronique des membres inférieurs en 2014 [Treatment of critical lower limb ischemia].
Salomon du Mont L., Déglise S., Dubuis C., Saucy F., Doenz F., Calanca L., Qanadli S., Mazzolai L., Corpataux J M, 2014/10. Revue Médicale Suisse, 10 (447) pp. 1992-1996. Peer-reviewed.
 
Maladies vasculaires rares [Rare vascular diseases].
Calanca L., Depairon M., Tribout B., Aebischer N., Burnier M., Fellmann F., Lazor R., Mazzolai L., 2014/02. Revue Médicale Suisse, 10 (416) pp. 347-50, 352.
 
Clinical outcome in patients with venous thromboembolism receiving concomitant anticoagulant and antiplatelet therapy.
Tzoran I., Brenner B., Sakharov G., Trujillo-Santos J., Lorenzo A., Madridano O., López-Sáez J.B., Monreal M., RIETE investigators, 2014. European Journal of Internal Medicine, 25 (9) pp. 821-825. Peer-reviewed.
 
Coronary sinus atresia with persistent left superior vena cava: unusual clinical presentation and endovascular management.
Qanadli S.D., Rolf T., Glauser F., Delay D., Beigelman-Aubry C., Prêtre R., 2014. Cardiovascular and Interventional Radiology, 37 (3) pp. 825-828.
 
D-dimer levels and 90-day outcome in patients with acute pulmonary embolism with or without cancer.
Maestre A., Trujillo-Santos J., Visoná A., Lobo J.L., Grau E., Malý R., Duce R., Monreal M., RIETE Investigators, 2014. Thrombosis Research, 133 (3) pp. 384-389. Peer-reviewed.
Experimental peripheral arterial disease: new insights into muscle glucose uptake, macrophage, and T-cell polarization during early and late stages.
Pellegrin M., Bouzourène K., Poitry-Yamate C., Mlynarik V., Feihl F., Aubert J.F., Gruetter R., Mazzolai L., 2014. Physiological Reports, 2 (2) pp. e00234. Peer-reviewed.
 
Home versus in-hospital treatment of outpatients with acute deep venous thrombosis of the lower limbs.
Lozano F., Trujillo-Santos J., Barrón M., Gallego P., Babalis D., Santos M., Falgá C., Monreal M., RIETE Investigators, 2014. Journal of Vascular Surgery, 59 (5) pp. 1362-7.e1. Peer-reviewed.
 
Influence of recent immobilization or surgery on mortality in cancer patients with venous thromboembolism.
Trujillo-Santos J., Gussoni G., Gadelha T., Sänchez Muñoz-Torrero J.F., Barron M., Lopez L., Ruiz-Ruiz J., Fernandez-Capitan C., Lorente M., Monreal M. et al., 2014. Thrombosis Research, 133 (Suppl 2) pp. S29-S34. Peer-reviewed.
 
Interaction between widening of diameter of abdominal aorta and cardiovascular risk factors and atherosclerosis burden.
Glauser F., Mazzolai L., Darioli R., Depairon M., 2014. Internal and Emergency Medicine, 9 (4) pp. 411-417.
 
No major impact of skin aging on the response of skin blood flow to a submaximal local thermal stimulus.
Vionnet J., Calero-Romero I., Heim A., Rotaru C., Engelberger R.P., Dischl B., Noël B., Liaudet L., Waeber B., Feihl F., 2014. Microcirculation, 21 (8) pp. 730-737. Peer-reviewed.
 
Outcomes in neurosurgical patients who develop venous thromboembolism: a review of the RIETE registry.
Cote L.P., Greenberg S., Caprini J.A., Stone J., Arcelus J.I., López-Jiménez L., Rosa V., Schellong S., Monreal M., RIETE Investigators, 2014. Clinical and Applied Thrombosis/hemostasis, 20 (8) pp. 772-778. Peer-reviewed.
 
Sex differences in patients receiving anticoagulant therapy for venous thromboembolism.
Blanco-Molina A., Enea I., Gadelha T., Tufano A., Bura-Riviere A., Di Micco P., Bounameaux H., González J., Villalta J., Monreal M. et al., 2014. Medicine, 93 (17) pp. 309-317. Peer-reviewed.
 
Thrombosis of palmar and interdigital arteries in the hypereosinophilic syndrome.
Gallardo C., Mancinetti M., Périard D., Hayoz D., 2014. Vasa. Zeitschrift Für Gefässkrankheiten, 43 (3) pp. 222-224. Peer-reviewed.
Use of plasma Renin activity to monitor mineralocorticoid treatment in dogs with primary hypoadrenocorticism: desoxycorticosterone versus fludrocortisone.
Baumstark M.E., Nussberger J., Boretti F.S., Baumstark M.W., Riond B., Reusch C.E., Sieber-Ruckstuhl N.S., 2014. Journal of Veterinary Internal Medicine, 28 (5) pp. 1471-1478. Peer-reviewed.
 
Variabilité des concentrations plasmatiques de l'angiotensinogène et risque d'hypertension artérielle chez le rat transgénique [Variability of plasma angiotensinogen levels and risk of hypertension in a transgenic rat model].
Gudo B., Nussberger J., Bohlender J., 2014. Annales de Cardiologie et d'angéiologie, 63 (3) pp. 124-127. Peer-reviewed.
 
A clinical prognostic model for the identification of low-risk patients with acute symptomatic pulmonary embolism and active cancer.
den Exter P.L., Gómez V., Jiménez D., Trujillo-Santos J., Muriel A., Huisman M.V., Monreal M., Registro Informatizado de la Enfermedad TromboEmbólica (RIETE) Investigators, 2013. Chest, 143 (1) pp. 138-145.
 
Active mitral ring for post-surgical remote correction of residual mitral regurgitation on the beating heart.
Tozzi P., Locca D., Gronchi F., Hayoz D., Ferrari E., von Segesser L.K., Hullin R., 2013. European Journal of Cardio-Thoracic Surgery, 44 (2) pp. 370-374.
Angiotensin II as an Inducer of Atherosclerosis: Evidence from Mouse Studies
Pellegrin M., Mazzolai L., 2013. Journal of Clinical and Experimental Cardiology, 1 (S1) p. 007.
 
Angiotensinergic innervation of the kidney: present knowledge and its significance.
Bohlender J., Nussberger J., Imboden H., 2013. Current Hypertension Reports, 15 (1) pp. 10-16. Peer-reviewed.
 
Anévrismes de l'artère poplitée: quelle prise en charge en 2013 ? [Popliteal artery aneurysms: management in 2013].
Dubuis C., Déglise S. , Saucy F., Holzer T., Calanca L., Mazzolai L., Doenz F., Qanadli S.D., Corpataux J.M., 2013. Revue Médicale Suisse, 9 (391) pp. 1299-1304.
 
Bradykinin in blood and cerebrospinal fluid after acute cerebral lesions: correlations with cerebral edema and intracranial pressure.
Kunz M., Nussberger J., Holtmannspötter M., Bitterling H., Plesnila N., Zausinger S., 2013. Journal of Neurotrauma, 30 (19) pp. 1638-1644.
 
Deep vein thrombosis of the penis: an unusual but severe complication of prostatic abscess.
Calanca L., Alatri A., Schaller M.D., Sermier A., Mazzolai L., 2013. Vasa. Zeitschrift Für Gefässkrankheiten, 42 (3) pp. 214-217.
 
Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism.
Lecumberri R., Alfonso A., Jiménez D., Fernández Capitán C., Prandoni P., Wells P.S., Vidal G., Barillari G., Monreal M., RIETE investigators, 2013. Thrombosis and Haemostasis, 110 (4) pp. 834-843.
 
Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.
Hokusai-VTE Investigators, Büller H.R., Büller H.R., Décousus H., Grosso M.A., Mercuri M., Middeldorp S., Prins M.H., Raskob G.E., Schellong S.M. et al., 2013. New England Journal of Medicine, 369 (15) pp. 1406-1415.
Endothelial mineralocorticoid receptor activation mediates endothelial dysfunction in diet-induced obesity.
Schäfer N., Lohmann C., Winnik S., van Tits L.J., Miranda M.X., Vergopoulos A., Ruschitzka F., Nussberger J., Berger S., Lüscher T.F. et al., 2013. European Heart Journal, 34 (45) pp. 3515-3524.
 
European guidelines for sclerotherapy in chronic venous disorders.
Rabe E., Breu F., Cavezzi A., Smith P.C., Frullini A., Gillet J., Guex J., Hamel-Desnos C., Kern P., Partsch B. et al., 2013. Phlebology / Venous Forum of the Royal Society of Medicine, 29 (6) pp. 338-354. Peer-reviewed.
 
Exercise-induced platelet activation in essential hypertension: have we solved the puzzle? Reply.
Kahan T., Schwieler J.H., Wallén H., Nussberger J., Hjemdahl P., 2013. Journal of Hypertension, 31 (9) p. 1917.
 
Factors associated with elevated pulmonary arterial pressure levels on the echocardiographic assessment in patients with prior pulmonary embolism.
Otero R., Elías T., Jara L., Trujillo-Santos J., Bertoletti L., Nauffal D., Ruiz-Ruiz J., Blanco-Molina Á., Monreal M., RIETE investigators, 2013. Thrombosis Research, 131 (5) pp. e191-e195.
 
Inhibition of the renin-angiotensin system does not reduce platelet activity at rest or during stress in hypertension.
Schwieler J.H., Kahan T., Wallén N.H., Nussberger J., Hjemdahl P., 2013. Journal of Hypertension, 31 (8) pp. 1676-1682.
 
La dénervation rénale unilatérale et le système kallikréine-bradykinine rénal chez le rat [Unilateral renal denervation and the renal kallikrein-bradykinin system in the rat].
Bohlender J., Nussberger J., Amstutz C., Birkhäuser F., Thalmann G.N., Imboden H., 2013. Annales de Cardiologie et d'angéiologie, 62 (3) pp. 144-148.
 
Low-molecular-weight or unfractionated heparin in venous thromboembolism: the influence of renal function.
Trujillo-Santos J., Schellong S., Falga C., Zorrilla V., Gallego P., Barrón M., Monreal M., RIETE Investigators, 2013. American Journal of Medicine, 126 (5) pp. 425-434.e1.
 
Pharmacotherapy: Optimal blockade of the renin-angiotensin-aldosterone system.
Nussberger J., Bohlender J., 2013. Nature Reviews. Cardiology, 10 (4) pp. 183-184.
 
Platelet activation during exercise is not attenuated by inhibition of the renin angiotensin system: the role of physical activity.
Kahan T., Schwieler J.H., Wallén H., Nussberger J., Hjemdahl P., 2013. Journal of Hypertension, 31 (10) pp. 2103-2104.
 
Platelet count and outcome in patients with acute venous thromboembolism.
Di Micco P., Ruiz-Giménez N., Nieto J.A., Aujesky D., del Molino F., Valle R., Barrón M., Maestre A., Monreal M., RIETE investigators, 2013. Thrombosis and Haemostasis, 110 (5) pp. 1025-1034.
 
Quet anticoagulant pour quel patient [Which anticoagulant agent for which patient?].
Righini M., Mazzolai L., de Moerloose P., 2013. Revue Médicale Suisse, 9 (372) pp. 299-300.
Reduction of connexin36 content by ICER-1 contributes to insulin-secreting cells apoptosis induced by oxidized LDL particles.
Haefliger J.A., Martin D., Favre D., Petremand Y., Mazzolai L., Abderrahmani A., Meda P., Waeber G., Allagnat F., 2013. PLOS One, 8 (1) pp. e55198.
 
Reply: Optimal renin-angiotensin-aldosterone system blockade--wish fulfilled.
Nussberger J., Bohlender J., 2013. Nature Reviews. Cardiology, 10 (8) p. 486.
 
Syndrome de l'artère poplitée piégée [Popliteal artery entrapment syndrome].
Calanca L., Glauser F., Alatri A., Mazzolai L., 2013. Revue Médicale Suisse, 9 (372) pp. 311-314.
 
The Swiss cohort of elderly patients with venous thromboembolism (SWITCO65+): rationale and methodology.
Méan M., Righini M., Jaeger K., Beer H.J., Frauchiger B., Osterwalder J., Kucher N., Lämmle B., Cornuz J., Angelillo-Scherrer A. et al., 2013. Journal of Thrombosis and Thrombolysis, 36 (4) pp. 475-483.
 
Validation of a score for predicting fatal bleeding in patients receiving anticoagulation for venous thromboembolism.
Nieto J.A., Solano R., Trapero Iglesias N., Ruiz-Giménez N., Fernández-Capitán C., Valero B., Tiberio G., Bura-Riviere A., Monreal M., RIETE Investigators, 2013. Thrombosis Research, 132 (2) pp. 175-179.
 
Impact of carotid plaque screening on smoking cessation and other cardiovascular risk factors: a randomized controlled trial.
Rodondi Nicolas, Collet Tinh-Hai, Nanchen David, Locatelli Isabella, Depairon Michèle, Aujesky Drahomir, Bovet Pascal, Cornuz Jacques, 2012/02. Archives of Internal Medicine, 172 (4) pp. 344-352. Peer-reviewed.
 
Aliskiren penetrates adipose and skeletal muscle tissue and reduces renin-angiotensin system activity in obese hypertensive patients.
Boschmann M., Nussberger J., Engeli S., Danser A.H., Yeh C.M., Prescott M.F., Dahlke M., Jordan J., 2012. Journal of Hypertension, 30 (3) pp. 561-566.
 
Angiotensinergic innervation of the kidney: Localization and relationship with catecholaminergic postganglionic and sensory nerve fibers.
Bohlender J., Pfarrer B., Patil J., Nussberger J., Thalmann G.N., Imboden H., 2012. Histology and Histopathology, 27 (11) pp. 1413-1428.
 
Angiotensinergic neurotransmission in the peripheral autonomic nervous system.
Bohlender J., Imboden H., 2012. Frontiers in Bioscience, 17 pp. 2419-2432. Peer-reviewed.
 
Artificial muscle for end-stage heart failure.
Tozzi P., Michalis A., Hayoz D., Locca D., von Segesser L.K., 2012. Asaio Journal, 58 (2) pp. 103-108. Peer-reviewed.
 
Assessment of coronary vasoreactivity by multidetector computed tomography: feasibility study with rubidium-82 cardiac positron emission tomography.
Dunet V., Qanadli S.D., Allenbach G., Dabiri A., Mazzolai L., Waeber B., Feihl F., Prior J.O., 2012. Circulation journal : official journal of the Japanese Circulation Society, 76 (1) pp. 160-167. Peer-reviewed.
 
Blood pressure and renin-angiotensin system resetting in transgenic rats with elevated plasma Val5-angiotensinogen.
Bohlender J., Bader M., Ménard J., Nussberger J., 2012. Journal of Hypertension, 30 (8) pp. 1597-1605.
 
Changes in Aortic Pulse Wave Velocity in Hypertensive Postmenopausal Women: Comparison Between a Calcium Channel Blocker vs Angiotensin Receptor Blocker Regimen.
Hayoz D., Zappe D.H., Meyer M.A., Baek I., Kandra A., Joly M.P., Mazzolai L., Haesler E., Periard D., 2012. Journal of Clinical Hypertension, 14 (11) pp. 773-778.
 
Desensitization of thermal hyperemia in the skin is reproducible.
Frantz J., Engelberger R.P., Liaudet L., Mazzolai L., Waeber B., Feihl F., 2012. Microcirculation, 19 (1) pp. 78-85. Peer-reviewed.
 
Dual RAAS suppression: recent developments and implications in light of the ALTITUDE study.
de Boer R.A., Azizi M., Danser A.J., Nguyen G., Nussberger J., Ruilope L.M., Schmieder R.E., Volpe M., 2012. Journal of the Renin-Angiotensin-Aldosterone System, 13 (3) pp. 409-412.
Fluorine-19 Magnetic Resonance Imaging in a Mouse Model of Atherosclerosis. Subject: Cardiovascular MRI
van Heeswijk R., Pellegrin M., Mazzolai L., Flögel U., Schwitter J., Stuber M., 2012. p. 3945 dans ISMRM 2012, 20th Annual Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine, SMRT 21st Annual Meeting of the Section for Magnetic Resonance Technologists, Proceedings of the International Society for Magnetic Resonance in Medicine.
 
Intravital microscopy reveals endothelial dysfunction in resistance arterioles in Angiotensin II-induced hypertension.
Schäfer S.C., Pellegrin M., Wyss C., Aubert J.F., Nussberger J., Hayoz D., Lehr H.A., Mazzolai L., 2012. Hypertension Research, 35 (8) pp. 855-861.
Mesure de l'index bras-cheville pour le dépistage des artériopathies oblitérantes périphériques
Monti M., Mazzolai L., 2012. Swiss Medical Forum, 12 (27-28) pp. 549-553. Peer-reviewed.
 
Potassium restores vasorelaxation of resistance arterioles in non-hypertensive DOCA/salt fed mice.
Wyss C., Wang Q., Golshayan D., Nussberger J., Burnier M., Lehr H.A., Schaefer S.C., 2012. Microvascular Research, 84 (3) pp. 340-344.
 
Primärer Hyperaldosteronismus bei Katzen [Primary hyperaldosteronism in cats].
Willi B., Kook P.H., Quante S., Boretti F., Sieber-Ruckstuhl N.S., Grest P., Scherrer O., Riond B., Hofmann-Lehmann R., Nussberger J. et al., 2012. Schweizer Archiv für Tierheilkunde, 154 (12) pp. 529-537.
 
Prise en charge du syndrome post-thrombotique [Management of post-thrombotic syndrome].
Alatri A., Mazzolai L., 2012. Praxis, 101 (13) pp. 843-848.
 
Prospective comparison of clinical prognostic scores in elderly patients with pulmonary embolism.
Zwierzina D., Limacher A., Méan M., Righini M., Jaeger K., Beer H.J., Frauchiger B., Osterwalder J., Kucher N., Matter C.M. et al., 2012. Journal of Thrombosis and Haemostasis, 10 (11) pp. 2270-2276. Peer-reviewed.
 
Prévention de la maladie veineuse chronique: quels conseils donner à nos patients [Prevention of chronic venous disease: which advice for our patients?].
Glauser F., Codreanu A., Tribout B., Mazzolai L., Depairon M., 2012. Revue Médicale Suisse, 8 (327) pp. 306-310.
 
Prévention des troubles lymphatiques et de leurs complications [Lymphatic disorders and prevention of their complications].
Tomson D., Lessert C., Klumbach D., Mazzolai L., Depairon M., 2012. Revue Médicale Suisse, 8 (327) pp. 315-319.
 
Prévention du syndrome post-thrombotique [Prevention of post-thrombotic syndrome].
Alatri A., Calanca L., Tomson D., Mazzolai L., 2012. Revue Médicale Suisse, 8 (327) pp. 311-314.
 
Qualité de vie après traitement de l'insuffisance veineuse superficielle primaire. [Quality of life in patients traited for primary superficial venous insufficiency].
Marques-Vidal P., Imsand D., Kayoumi A., Kern Ph., Mazzolai L., Depairon M., 2012. Praxis, 101 (10) pp. 645-650.
 
Reduction of small infrarenal abdominal aortic aneurysm expansion rate by statins.
Periard D., Guessous I., Mazzolai L., Haesler E., Monney P., Hayoz D., 2012. VASA, 41 (1) pp. 35-42. Peer-reviewed.
 
Results of a consensus meeting on the use of argatroban in patients with heparin-induced thrombocytopenia requiring antithrombotic therapy - a European Perspective.
Alatri A., Armstrong A.E., Greinacher A., Koster A., Kozek-Langenecker S.A., Lancé M.D., Link A., Nielsen J.D., Sandset P.M., Spanjersberg A.J. et al., 2012. Thrombosis Research, 129 (4) pp. 426-433.
 
Rééducation vasculaire du patient artériopathe [Vascular rehabilitation of patients suffering from peripheral arterial disease].
Calanca L., Alatri A., Junod N., Theurillat C., Mazzolai L., 2012. Revue Médicale Suisse, 8 (327) pp. 302-305.
 
Sclerotherapy of telangiectasias: a painless two-step technique.
Kern P., 2012. Dermatologic Surgery, 38 (6) pp. 860-864.
 
Suivi angiologique des patients artériopathes après geste de revascularisation [Vascular follow up in patients suffering peripheral arterial disease and undergoing revascularization].
Codreanu A., Calanca L., Glauser F., Corpataux J.M., Qanadli S., Mazzolai L., Depairon M., 2012. Revue Médicale Suisse, 8 (327) pp. 324-327. Peer-reviewed.
 
The Effect of Valsartan versus Non-RAAS Treatment on Autoregulation of Cerebral Blood Flow.
Périard D., Rey M.A., Casagrande D., Vesin J.M., Carrera E., Hayoz D., 2012. Cerebrovascular Diseases, 34 (1) pp. 78-85.
 
Vasopressin V(1a) receptors mediate posthemorrhagic systemic hypertension thereby determining rebleeding rate and outcome after experimental subarachnoid hemorrhage.
Hockel K., Schöller K., Trabold R., Nussberger J., Plesnila N., 2012. Stroke, 43 (1) pp. 227-232.
 
Vorapaxar in the secondary prevention of atherothrombotic events.
Morrow D.A., Braunwald E., Bonaca M.P., Ameriso S.F., Dalby A.J., Fish M.P., Fox K.A., Lipka L.J., Liu X., Nicolau J.C. et al., 2012. New England Journal of Medicine, 366 (15) pp. 1404-1413.
X-ray phase contrast grating inferometry for atherosclerosis imaging in mice. Session XII: New Acquisition Techniques and Processing Methods (3). Abstract
van Heeswijk R., Modregger P., Coppo S., Bonanno G., Pellegrin M., Aubert J.F., Stampanoni M., Mazzolai L., Stuber M., 2012. dans MRA 2012, 24th Annual International Conference of the Magnetic Resonance Angiography Working Group.
Sclérothérapie : explications pour le patient
Centre Hospitalier Universitaire Vaudois. Service d'Angiologie , Policlinique médicale universitaire (Lausanne) , 2011/11. 2.
Traitement des varices : laser endoveineux : votre angiologue vous informe
Centre Hospitalier Universitaire Vaudois. Service d'Angiologie , 2011/11. 6.
Traitement des varices : phlébectomie : votre angiologue vous informe
Centre Hospitalier Universitaire Vaudois. Service d'Angiologie , 2011/11. 6.
Traitement des varices : sclérothérapie échoguidée : votre angiologue vous informe
Centre Hospitalier Universitaire Vaudois. Service d'Angiologie , 2011/11. 6.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Fax. +41 21 692 26 15
Swiss University